Trials / Completed
CompletedNCT05224622
Detection of COVID-19 Using Breath Analysis - Validation Study.
Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 192 (actual)
- Sponsor
- Scentech Medical Technologies Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Detection of the 2019 novel Coronavirus (SARS-CoV-2) using breath analysis - Validation study.
Detailed description
A diagnostic prospective single-site study, with no anticipated risks or constraints. Primary objective- To validate the value of a set of breath VOC biomarkers that enable the investigator to distinguish between COVID-19 carriers and COVID-19 non-carriers in comparison to the gold-standard testing methodology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | VOX | Breath exhalation into the mouthpiece of the VOX breath diagnostic device. |
Timeline
- Start date
- 2022-01-18
- Primary completion
- 2022-05-28
- Completion
- 2023-01-18
- First posted
- 2022-02-04
- Last updated
- 2023-05-31
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT05224622. Inclusion in this directory is not an endorsement.